A randomized, placebo-controlled trial of varenicline, a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist, as a new therapy for smoking cessation in Asian smokers.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples